Citation: F. Liard et al., PHARMACOKINETIC ASPECTS OF PALINAVIR, AN HIV PROTEASE INHIBITOR, IN SPRAGUE-DAWLEY RATS, Journal of pharmaceutical sciences, 87(6), 1998, pp. 782-785
Authors:
LEFLOCH JP
DUPRATLOMON I
ESCHWEGE EL
LIARD F
GRIMALDI A
Citation: Jp. Lefloch et al., MANAGEMENT OF 5548 PATIENTS WITH TYPE-II DIABETES FOLLOWED BY GENERAL-PRACTITIONERS IN FRANCE, 1997, Diabetes, 47, 1998, pp. 1486-1486
Authors:
BOLGER GT
ALLEN T
GARNEAU M
LAPEYRE N
LIARD F
JARAMILLO J
Citation: Gt. Bolger et al., CUTANEOUSLY APPLIED ACYCLOVIR ACTS SYSTEMICALLY IN THE TREATMENT OF HERPETIC INFECTION IN THE HAIRLESS MOUSE, Antiviral research, 35(3), 1997, pp. 157-165
Authors:
BEAULIEU PL
WERNIC D
ABRAHAM A
ANDERSON PC
BOGRI T
BOUSQUET Y
CROTEAU G
GUSE I
LAMARRE D
LIARD F
PARIS W
THIBEAULT D
PAV S
TONG L
Citation: Pl. Beaulieu et al., POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDEISOSTERE, Journal of medicinal chemistry, 40(14), 1997, pp. 2164-2176
Citation: F. Liard et al., DETERMINATION OF THE HIV PROTEASE INHIBITOR BILA-2185-BS IN RAT PLASMA BY LIQUID-LIQUID-EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY PHOTODIODE-ARRAY DETECTOR, Journal of pharmaceutical and biomedical analysis, 14(1-2), 1995, pp. 151-154
Authors:
GENTHON R
RANGOONWALA B
ANDRIEUXLACLAVELINE A
ARNAUD J
BALLADE M
BILLOU J
BOSREDON A
BOUTGES B
DUBON T
GOIGOUX B
LALANNE G
LAURENTJOYE F
LION A
LORANS P
MAURAT X
MOULINET P
RICARD L
ROCHE A
SDRIGOTTI D
SDRIGOTTI J
BUGNON P
DELOGE J
GENIN M
JACSON P
LAMIZET P
MOURAUX J
STRAUSS P
TAQUE R
VINCENT J
BOULEN Y
BOYAVAL B
DANDOY P
DELESCLUSE D
DENIS X
DERMAUT G
DEROIDE F
GHIENNE JP
HERMEL R
JAILLARD T
MANIGLIER G
MEURISSE F
RICHARD G
TIBERGHIEN P
VANDENDRIESSCHE P
VANNIER P
AGNIEL P
ARMAND C
BOICHON P
BOULE G
CHAPPUY D
CORMARY M
DUMORTIER J
DURAND JY
GUEZ C
HOBEIKA A
HUCHON J
LEAMMER G
LAFUMA G
LEVRAT P
MEDIONI J
MORIN MM
CASABIANCACHICKLY M
CECILE A
DEREGIS H
DESENCLOS J
LEMIERE JM
OVANON G
RAINITSIMBA M
RECORBET G
ROBIN P
ZINI G
BAUMANN M
BOCCARA J
COUDRY A
DIETRICH J
FROIDEVAUX J
KENTZINGER J
MEYER P
NEFF G
PICA D
ROBERT J
VOGT P
COZIC J
DAHAN G
DARTIGE JJ
ELKOURI J
EOCHE R
FORTIS A
GOURE P
HAMEL NH
LECOY C
MANSEAU J
PERIMONY C
PIQUET P
PONTONNIER J
SUPIOT JL
BENDAVID N
BERGER P
COLETTI M
HADJADJ P
HOLSTEIN M
ROUGERON C
SERERO A
ANDRES F
ATTUIL R
BEFORT A
BIDET P
BIRRY G
GUY I
HARTMANN G
SCHLEWITZ T
COCHET D
COGNEAU J
CONAN M
FITOUSSI W
GIACOMINO A
LEBLEU P
LECALIER A
LIARD F
PALEOLOGUE F
PERSONNIC S
ROFFAY J
SALMON T
SERRE C
THIMEL S
BAUER B
LENDRESSE P
CARCONE N
DELMAS F
DENAES R
SADORGE C
DEROBERT E
LEMARIE JC
THEOBALD KH
BOURDEREAU G
IROUDAYASSAMY R
SAMSONTHOMAS L
FRAMPTON H
CARRE A
FILLASTRE JP
GALLET M
IMBS JL
PLOUIN PF
Citation: R. Genthon et al., STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION RAMIPRIL 2.5-MG PLUS HYDROCHLOROTHIAZIDE 12.5-MG IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, International journal of clinical pharmacology research, 14(1), 1994, pp. 1-9